{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:12Z","timestamp":1786984392130,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.anl.2015.08.014","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T09:04:44Z","timestamp":1444381484000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan"],"prefix":"10.1016","volume":"43","author":[{"given":"Takeshi","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Suzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2015.08.014_bib0355","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0360","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.anl.2015.08.014_bib0365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0370","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.05020234","article-title":"Erythromycin inhibits Cl secretion across canine tracheal epithelial cells","volume":"5","author":"Tamaoki","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anl.2015.08.014_bib0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jac\/29.2.173","article-title":"Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro","volume":"29","author":"Tamaoki","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0380","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm.156.1.9612065","article-title":"Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells","volume":"156","author":"Takizawa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0385","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/bbrc.1999.1917","article-title":"Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells","volume":"267","author":"Desaki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anl.2015.08.014_bib0390","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.04.00057104","article-title":"Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro","volume":"23","author":"Kanai","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anl.2015.08.014_bib0395","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/ajrccm\/146.1.196","article-title":"Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients","volume":"146","author":"Ichikawa","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.anl.2015.08.014_bib0400","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkf008","article-title":"Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors","volume":"49","author":"Kikuchi","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0405","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.45.6.1930-1933.2001","article-title":"Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa","volume":"45","author":"Tateda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0410","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkf013","article-title":"Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model","volume":"49","author":"Yanagihara","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0415","first-page":"29","article-title":"The effects of low-dose long-term erythromycin administration treatment on chronic rhinosinusitis complicated by diffuse panbronchiolitis","volume":"11","author":"Suzaki","year":"1990","journal-title":"Ther Res"},{"key":"10.1016\/j.anl.2015.08.014_bib0420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5631\/jibirin.84.41","article-title":"Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis","volume":"84","author":"Kikuchi","year":"1991","journal-title":"Pract Otol (Kyoto)"},{"key":"10.1016\/j.anl.2015.08.014_bib0425","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.5631\/jibirin.85.1245","article-title":"Long-term low-dose erythromycin therapy for chronic sinusitis","volume":"85","author":"Kikuchi","year":"1992","journal-title":"Pract Otol (Kyoto)"},{"key":"10.1016\/j.anl.2015.08.014_bib0430","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004050050222","article-title":"Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells","volume":"257","author":"Fujita","year":"2000","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2015.08.014_bib0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","article-title":"Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage","volume":"14","author":"Yamada","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.anl.2015.08.014_bib0440","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2169\/internalmedicine.34.469","article-title":"Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity","volume":"34","author":"Shirai","year":"1995","journal-title":"Int Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0445","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/iai.62.10.4145-4152.1994","article-title":"Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airway of patient with chronic airway diseases","volume":"62","author":"Oishi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.anl.2015.08.014_bib0450","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaff\u00e9","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2015.08.014_bib0455","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2015.08.014_bib0460","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1378\/chest.99.3.670","article-title":"Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma","volume":"99","author":"Miyatake","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.anl.2015.08.014_bib0465","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/all.12199","article-title":"Macrolides for the long-term management of asthma \u2013 a meta-analysis of randomized clinical trials","volume":"68","author":"Reiter","year":"2013","journal-title":"Allergy"},{"issue":"Suppl. 9A","key":"10.1016\/j.anl.2015.08.014_bib0470","first-page":"20S","article-title":"Clinical implications of the immunomodulatory effects of macrolides on sinusitis","volume":"117","author":"Majima","year":"2004","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.anl.2015.08.014_bib0475","first-page":"126S","article-title":"The effects of a long-term and low-dose administration of clarithromycin in chronic sinusitis","volume":"40","author":"Majima","year":"1997","journal-title":"Oto-Rhino-Laryngology (Tokyo)"},{"key":"10.1016\/j.anl.2015.08.014_bib0480","series-title":"The handbook of management of chronic rhinosinusitis","first-page":"49","article-title":"Macrolide therapy","author":"Japan Rhinologic Society","year":"2007"},{"key":"10.1016\/j.anl.2015.08.014_bib0485","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.04.00084304","article-title":"Azithromycin for cystic fibrosis","volume":"24","author":"Southern","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anl.2015.08.014_bib0490","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","article-title":"A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis","volume":"116","author":"Wallwork","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2015.08.014_bib0495","first-page":"97","article-title":"EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists","volume":"45","author":"Fokkens","year":"2007","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2015.08.014_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2015.08.014_bib0505","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","article-title":"Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial","volume":"66","author":"Videler","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2015.08.014_bib0510","series-title":"Nasal physiology and pathophysiology of nasal disorders","first-page":"1","article-title":"Mucus, goblet cell, submucosal gland","author":"Shimizu","year":"2013"},{"key":"10.1016\/j.anl.2015.08.014_bib0515","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/ajrccm.160.2.9805117","article-title":"Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis","volume":"160","author":"Majima","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0520","first-page":"259","article-title":"Macrolide therapy of chronic rhinosinusitis","volume":"45","author":"Cervin","year":"2007","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2015.08.014_bib0525","first-page":"14","article-title":"Clinical study and action mechanisms of macrolide therapy for chronic rhinosinusitis","volume":"1","author":"Suzaki","year":"2013","journal-title":"Asian Rhinol J"},{"key":"10.1016\/j.anl.2015.08.014_bib0530","first-page":"166","article-title":"Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy","volume":"33","author":"Moriyama","year":"1995","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2015.08.014_bib0535","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.anl.2012.09.009","article-title":"Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery","volume":"40","author":"Nakamura","year":"2013","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2015.08.014_bib0540","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anl.2011.04.015","article-title":"Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp","volume":"39","author":"Majima","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2015.08.014_bib0545","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","article-title":"Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections","volume":"39","author":"Tamaoki","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0550","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/ajrccm\/147.1.153","article-title":"A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis","volume":"147","author":"Kadota","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.anl.2015.08.014_bib0555","first-page":"L15","article-title":"Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides","volume":"272","author":"Tamaoki","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.anl.2015.08.014_bib0560","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000027731","article-title":"Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy","volume":"62","author":"Suzuki","year":"2000","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.anl.2015.08.014_bib0565","first-page":"66","article-title":"A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis","volume":"47","author":"Haruna","year":"2009","journal-title":"Rhinology"},{"key":"10.1016\/j.anl.2015.08.014_bib0570","doi-asserted-by":"crossref","first-page":"717","DOI":"10.5631\/jibirin.90.717","article-title":"Clinical efficacy of long-term macrolide therapy for chronic rhinosinusitis \u2013 comparison between erythromycin and clarithromycin","volume":"90","author":"Hashiba","year":"1997","journal-title":"Pract Otol (Kyoto)"},{"key":"10.1016\/j.anl.2015.08.014_bib0575","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","article-title":"The levels of clarithromycin and its 14-hydroxy metabolite in the lung","volume":"7","author":"Honeybourne","year":"1994","journal-title":"Eur Respir J"},{"issue":"Suppl. A","key":"10.1016\/j.anl.2015.08.014_bib0580","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/27.suppl_A.61","article-title":"The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans","volume":"27","author":"Fraschini","year":"1991","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anl.2014.05.022","article-title":"Practical guideline for management of acute rhinosinusitis in Japan","volume":"42","author":"Yamanaka","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2015.08.014_bib0590","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2015.08.014_bib0595","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2015.08.014_bib0600","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archotol.1993.01880180064012","article-title":"Erythromycin therapy for otitis media with effusion in sinobronchial syndrome","volume":"119","author":"Iino","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2015.08.014_bib0605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.anl.2015.08.014_bib0610","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/jac\/dki297","article-title":"The Alexander Project: the benefits from a decade of surveillance","volume":"56","author":"Felmingham","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.08.014_bib0615","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.mlg.0000154740.48314.d5","article-title":"Increase of macrolide-resistant Streptococcus pneumoniae-expressing mefE or ermB gene in the nasopharynx among children with otitis media","volume":"115","author":"Hotomi","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2015.08.014_bib0620","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.bmcl.2011.04.004","article-title":"Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and\/or immunomodulatory agents","volume":"21","author":"Sugawara","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.anl.2015.08.014_bib0625","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.anl.2015.02.003","article-title":"Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium","volume":"42","author":"Tojima","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2015.08.014_bib0630","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000334339","article-title":"Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line","volume":"88","author":"Otsu","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.anl.2015.08.014_bib0635","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/bph.12574","article-title":"Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge","volume":"171","author":"Balloy","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.anl.2015.08.014_bib0640","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2011.04.036","article-title":"Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis","volume":"665","author":"Mencarelli","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.anl.2015.08.014_bib0645","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.anl.2015.08.014_bib0650","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0655","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0660","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/ajrccm.157.3.9703098","article-title":"Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice","volume":"157","author":"Sato","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0665","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anl.2015.08.014_bib0670","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","article-title":"Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells","volume":"83","author":"Asada","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.anl.2015.08.014_bib0675","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1164\/ajrccm.165.8.2103094","article-title":"Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells","volume":"165","author":"Suzuki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0680","doi-asserted-by":"crossref","first-page":"e91293","DOI":"10.1371\/journal.pone.0091293","article-title":"Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study","volume":"9","author":"Kakeya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.anl.2015.08.014_bib0685","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1440-1843.2009.01639.x","article-title":"Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza","volume":"14","author":"Sawabuchi","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.anl.2015.08.014_bib0690","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.anl.2015.08.014_bib0695","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/529439","article-title":"Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia","volume":"46","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anl.2015.08.014_bib0700","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581461500214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581461500214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:31:58Z","timestamp":1759951918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038581461500214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S038581461500214X"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2015.08.014","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2015.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}